• OPEN AN ACCOUNT
Indian Indices
Nifty
24,813.45 129.55
(0.52%)
Sensex
81,596.63 410.19
( 0.51%)
Bank Nifty
55,075.10 197.75
( 0.36%)
Nifty IT
37,540.10 256.60
( 0.69%)
Global Indices
Nasdaq
42,705.04 -108.03
(-0.25%)
Dow Jones
5,962.37 -22.23
(-0.37%)
Hang Seng
37,467.16 -31.47
(-0.08%)
Nikkei 225
8,781.12 81.81
(0.94%)
Forex
USD-INR
85.43 -0.14
(-0.16%)
EUR-INR
95.92 0.38
(0.40%)
GBP-INR
114.01 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.25%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5304659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
165.94
37.04
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

CRP Risk Management Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday February 14 2025
Feb 14,2025
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ('Listing Regulations') we would like to inform you that the Board of Directors of CRP Risk Management Limited (the Company) at its Meeting held today i.e. Friday February 14 2025 has inter-alia considered overviewed the overall financial health & stability of the Company including examining financials & performance metrics of the Company.